Heidelberg Pharma AG banner

Heidelberg Pharma AG
DUS:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
DUS:HPHA
Watchlist
Price: 2.67 EUR -3.61% Market Closed
Market Cap: €124.4m

Wall St Price Targets

HPHA Price Targets Summary
Heidelberg Pharma AG

Wall Street analysts forecast HPHA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HPHA is 5.37 EUR with a low forecast of 5.32 EUR and a high forecast of 5.53 EUR.

Lowest Forecast
Price Target
5.32 EUR
99% Upside
Average Forecast
Price Target
5.37 EUR
101% Upside
Highest Forecast
Price Target
5.53 EUR
107% Upside
Heidelberg Pharma AG Competitors:
Price Targets
UFPT
UFP Technologies Inc
56% Upside
FULT
Fulton Financial Corp
10% Upside
ADSK
Autodesk Inc
33% Upside

Revenue
Forecast

1% / Year
Past Growth
202% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss
1% / Year
Past Growth
202% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HPHA's stock price target?
Price Target
5.37 EUR

According to Wall Street analysts, the average 1-year price target for HPHA is 5.37 EUR with a low forecast of 5.32 EUR and a high forecast of 5.53 EUR.

What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%

Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett